COVID-19 and pregnancy: a review of current knowledge

Parisa Maleki Dana1, Fariba Kolahdooz2, Fatemeh Sadoughi3

  • 1Research Center for Biochemistry and Nutrition in Metabolic Diseases, Institute for Basic Sciences, Kashan University of Medical Sciences, Kashan, Iran.

Insights

Pregnant women infected with coronavirus disease 2019 (COVID-19) do not face higher risks for critical pneumonia. However, maternal COVID-19 infection can lead to adverse fetal outcomes like preterm labor and distress.

Area of Science:

  • Obstetrics and Gynecology
  • Infectious Diseases
  • Public Health

Background:

  • Coronavirus disease 2019 (COVID-19) emerged as a global health crisis in December 2019.
  • Previous viral infections (SARS, MERS, influenza) have been linked to adverse pregnancy outcomes.
  • The specific risks of COVID-19 for pregnant women and their fetuses require thorough investigation.

Purpose of the Study:

  • To summarize current research on COVID-19 symptoms in pregnant individuals.
  • To assess the potential risks of COVID-19 infection during pregnancy.
  • To review documented complications in fetuses and neonates born to mothers with COVID-19.

Main Methods:

  • Systematic review of studies published in English.
  • Data sourced from major scientific databases: Web of Science, Cochrane, PubMed, and Scopus.
  • Literature search conducted up to April 2nd, 2020, focusing on COVID-19 in pregnancy.

Main Results:

  • Common COVID-19 symptoms include fever, cough, dyspnea, myalgia, and fatigue.
  • Less frequent symptoms observed were sputum production, headache, hemoptysis, and diarrhea.
  • No evidence of vertical (maternal-fetal) transmission of COVID-19 was found.

Conclusions:

  • Clinical presentation of COVID-19 in pregnant women is similar to the general population.
  • Pregnant women with COVID-19 are not at increased risk for severe pneumonia compared to non-pregnant individuals.
  • While vertical transmission is not evident, maternal COVID-19 can precipitate preterm labor and fetal distress.
Abstract

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.8K
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by...
782
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.2K
CRISPR01:59

CRISPR

Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
57.1K
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
185
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
3.3K